Comparison of classical tumour growth models for patient derived and cell-line derived xenografts using the nonlinear

Dimitrios Voulgarelis1,2,3, Krishna C Bulusu2, James W T Yates1

  • 1DMPK Oncology R&D, AstraZeneca, Cambridge, UK.

Related Concept Videos